Credit Suisse’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-52,062
| Closed | -$148K | – | 3183 |
|
|
2023
Q1 | $148K | Buy |
52,062
+8,242
| +19% | +$23.5K | ﹤0.01% | 3153 |
|
|
2022
Q4 | $319K | Buy |
43,820
+21,230
| +94% | +$155K | ﹤0.01% | 2987 |
|
|
2022
Q3 | $183K | Buy |
22,590
+1,329
| +6% | +$10.8K | ﹤0.01% | 3260 |
|
|
2022
Q2 | $104K | Buy |
21,261
+3,105
| +17% | +$15.2K | ﹤0.01% | 3501 |
|
|
2022
Q1 | $429K | Sell |
18,156
-596
| -3% | -$14.1K | ﹤0.01% | 3043 |
|
|
2021
Q4 | $332K | Buy |
+18,752
| New | +$332K | ﹤0.01% | 3261 |
|